NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA, BELARUS OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED BY SWEDISH OR NORWEGIAN LAW.
Today, December 11, 2023, the subscription period begins in Genetic Analysis AS’ (“GA” or the “Company”) subsequent offering with gross proceeds of up to approximately NOK 9 million and 11,392,405 new shares with preferential rights for eligible existing shareholders (the “Subsequent Offering”). The subscription period in the Subsequent Offering lasts until December 22, 2023 at 12:00 (CET). Please note that trustees may have a final response date for subscription in the Subsequent Offering that falls before December 22, 2023 at 12:00. Oversubscription will be allowed for holders of subscription rights. Subscription without subscription rights will not be permitted. Furthermore, Genetic Analysis will tomorrow, December 12, 2023, at 10:00 (CET) digitally present the business and the Company’s future plans as well as answer questions. To join the live event please use the following link: https://www.finwire.tv/webcast/genetic-analysis/company-presentation/.
Timetable for the Subsequent Offering
- Subscription period: December 11, 2023 to December 22, 2023 at 12:00 hours (CET).
- Trading in subscription rights: December 11, 2023 to December 20, 2023 at 17:30 hours (CET)
- Announcement of the final outcome of the Subsequent Offering: around December 27, 2023
Information memorandum
The information memorandum, including complete terms and conditions and instructions of subscription and payment, is available on the Company’s and Sedermera Corporate Finance AB’s respective websites (www.genetic-analysis.com, www.sedermera.se).
Investor presentations
Tomorrow, December 12, 2023, at 10.00, CEO Ronny Hermansen will digitally present the business and the Company’s future plans as well as answer questions.To join the live event please use the following link: https://www.finwire.tv/webcast/genetic-analysis/company-presentation/.
Advisors
In connection with the Subsequent Offering, Sedermera Corporate Finance AB (www.sedermera.se) is appointed Swedish financial advisor and Advokatfirmaet Wiersholm AS is the Company’s Norwegian legal advisor.
For further information, please contact:
Ronny Hermansen, CEO
E-mail: rh@genetic-analysis.com
Eilert Aamodt, Chief Financial Officer
E-mail: ea@genetic-analysis.com
Please read the full press release:
How to subscribe for GA shares using your subscription rights?
The subscription form is available as a PDF file (for all investors) in Swedish language:
For investors domiciled in Norway, subscriptions are also available trough a digital form at Euronext Securities (former VPS) on the following link: